放射性医薬品市場：タイプ別、手技量別、用途別-2025年～2030年の世界予測

放射性医薬品市場は、2023年に51億5,000万米ドルと評価され、2024年には54億8,000万米ドルに達すると予測され、CAGR 6.47%で成長し、2030年には80億米ドルに達すると予測されています。

放射性医薬品は、医療分野における診断、治療、研究に使用される放射性化合物です。核医学において極めて重要な役割を担っており、主に画像診断や治療用途に使用されます。放射性医薬品の必要性は、特定の臓器、組織、細胞レセプターをターゲットとする能力からきており、それにより、がん、心臓血管疾患、神経疾患などの疾患の正確な画像診断と効果的な治療を可能にします。最終用途は主に病院、診断センター、専門クリニックです。成長に影響を与える主な要因としては、慢性疾患の有病率の増加、イメージング技術の進歩、正確な診断ツールや個別化治療戦略の需要を促進する老人人口の増加などが挙げられます。研究開発への投資の増加とともに、標的治療に対する放射性医薬品の急速な進歩は大きなビジネスチャンスをもたらしています。企業は、ニッチな適応症に焦点を当てたり、費用対効果の高い効率的な生産方法を開発することで、これらを活用することができます。

制約の1つは、放射性物質の取り扱いに固有の製造と規制遵守に関連する高コストであり、これが参入と技術革新の障壁となっています。加えて、高度なインフラと熟練した人材が必要なことも、市場の抑制要因に拍車をかけています。知的財産のハードルと長い承認プロセスが、急速な市場浸透をさらに複雑にしています。

事業成長のためには、より優れた有効性と副作用の少ない新しいアイソトープの研究が有望です。画像診断技術の革新や新たな臨床応用の開発は、事業拡大の道を開く可能性があります。また、放射性医薬品を既存の治療フレームワークにより効果的に統合するために、バイオテクノロジー企業とヘルスケアプロバイダーとのコラボレーションを模索する可能性もあります。

市場の性質上、規制が厳しく競争が激しいため、競争力を維持するためには研究開発への多額の投資が必要となります。ヘルスケア政策が進化し、テクノロジーが進歩する中、新興市場や未開拓のアプリケーションに焦点を当てることで、こうした変化に迅速に適応し、戦略的優位性を得ることができます。

市場力学：急速に進化する放射性医薬品市場の主要市場インサイトを公開

放射性医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 対象疾患の発生率と有病率の増加
  • アルファ線免疫療法に基づく標的がん治療
  • mo-99の需給ギャップを縮小する取り組み
• 市場抑制要因
  • 放射性医薬品の寿命短縮
• 市場機会
  • 神経アプリケーションにおける放射性医薬品の採用
  • 特に新興諸国における診断センター数の増加
• 市場の課題
  • 高い機器価格と限られた病院予算

ポーターの5つの力：放射性医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：放射性医薬品市場における外部からの影響の把握

外部マクロ環境要因は、放射性医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析放射性医薬品市場における競合情勢の把握

放射性医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス放射性医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、放射性医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 対象疾患の発生率と有病率の増加
    • アルファ放射免疫療法に基づく標的がん治療
    • mo-99の需給ギャップを縮小するための取り組み
  • 抑制要因
    • 放射性医薬品の寿命が短くなる
  • 機会
    • 神経学アプリケーションにおける放射性医薬品の採用
    • 診断センターの増加、特に新興諸国で増加
  • 課題
    • 高額な機器価格と限られた病院予算
• 市場セグメンテーション分析
  • 手技量：密封小線源治療同位元素手順の継続的な進歩
  • 用途：治療手順における放射性医薬品の利用率の向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 放射性医薬品市場：タイプ別

• 核医学診断
  • ペット放射性医薬品
    • F-18
    • Ru-82
  • スペクト放射性医薬品
    • ガ-67
    • I-123
    • TC-99M
    • TL-201
• 核医学治療
  • アルファ放射体
  • ベータ放射体
    • I-131
    • Lu-177
    • Re-186
    • SM-153
    • Y-90
  • 近接放射線治療同位元素
    • セシウム131
    • I-125
    • イリジウム192
    • PD-103

第7章 放射性医薬品市場：手技量別

• 診断手順
  • ペット放射性医薬品検査
  • Spect放射性医薬品手順
• 治療手順
  • アルファエミッター手順
  • ベータ放射体手順
  • 密封小線源治療同位元素手順

第8章 放射性医薬品市場：用途別

• 診断用途
  • ペット用途
    • 心臓病の適応
    • 神経学的適応
    • 腫瘍学の適応症
  • Spect用途
    • 心臓病学
    • リンパ腫
    • 神経学
    • 甲状腺
• 治療用途
  • 骨転移
  • 内分泌腫瘍
  • リンパ腫治療
  • 甲状腺治療

第9章 南北アメリカの放射性医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の放射性医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの放射性医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • ブリストルマイヤーズスクイブ、レイズバイオの買収によりプレミア放射性医薬品プラットフォームを追加
  • 新しいCRPが病気の診断のための新しいテクネチウム99m放射性医薬品を開発
  • メイヨー・クリニックの支援を受けたスタートアップが5,600万米ドルを調達し、放射性医薬品の障害に狙いを定める

企業一覧

• Global Medical Solutions
• Siemens Healthineers AG
• Fusion Pharmaceuticals Inc.
• Novartis AG
• International Isotopes, Inc.
• Northstar Medical Technologies LLC
• Institute of Isotopes Co. Ltd.
• Jubilant Pharma Holdings Inc.
• IsoTherapeutics Group, LLC
• Eckert & Ziegler Group
• Isotopia Molecular Imaging Ltd.
• GE HealthCare Technologies, Inc.
• BWX Technologies. Inc.
• Clarity Pharmaceuticals
• Eczacibasi-Monrol Nuclear Products Co.
• Alliance Holdings Medical Limited
• Cardinal Health, Inc.
• Mallinckrodt PLC
• Bracco Group
• NTP Radioisotopes SOC Ltd.
• Curium Pharma
• Medi-Radiopharma
• Sinotau Pharmaceutical Group
• State Atomic Energy Corporation Rosatom
• SHINE Medical Technologies
• Lantheus Medical Imaging, Inc.
• Bayer AG
• BWXT Medical Ltd.

LIST OF FIGURES

• FIGURE 1. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. RADIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RADIOPHARMACEUTICALS MARKET DYNAMICS
• TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 79. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 80. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 81. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 90. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 91. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 92. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 94. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 96. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 101. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 102. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 103. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 104. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 105. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 106. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 112. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 114. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 115. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 116. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 117. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 118. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 119. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 120. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 121. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 122. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 124. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 126. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 127. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 129. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 130. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 131. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 132. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 133. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 134. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 135. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 136. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 137. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 139. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 140. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 141. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 146. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 148. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 149. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 150. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 151. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 152. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 154. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 155. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 156. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 157. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 158. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 160. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 161. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 162. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 164. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 166. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 168. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 170. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 171. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 172. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 173. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 174. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 176. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 177. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 178. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 179. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 180. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 181. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 182. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 183. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 184. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 186. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 187. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 188. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 189. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 191. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 192. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 193. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 194. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 195. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 196. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 197. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 198. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 199. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 201. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 202. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 203. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 204. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 206. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 207. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 208. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 209. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 210. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 211. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 212. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 213. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 214. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 216. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 217. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 218. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 219. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 221. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 222. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 223. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 224. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 225. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 226. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 227. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 228. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 229. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 231. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 232. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 233. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 234. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 235. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 236. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 237. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 238. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 239. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 240. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 241. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 242. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 243. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 244. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 246. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 247. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 248. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 249. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 251. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 252. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 253. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 254. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 255. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 256. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 257. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 258. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 259. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 261. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 262. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 263. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 264. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 265. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 266. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 267. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 268. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 269. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 270. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 271. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 272. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 273. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 274. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 276. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 277. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 278. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 279. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 280. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 281. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 282. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 283. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 284. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 285. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 286. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 287. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 288. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 289. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 290. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 291. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 292. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 293. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 294. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 296. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 297. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 298. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 299. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 300. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 301. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 302. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 303. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 304. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 305. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 306. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 307. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 308. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 309. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 311. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 312. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 313. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
• TABLE 314. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
• TABLE 315. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
• TABLE 316. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
• TABLE 317. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 318. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
• TABLE 319. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 320. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 321. TAIWAN RADI

The Radiopharmaceuticals Market was valued at USD 5.15 billion in 2023, expected to reach USD 5.48 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 8.00 billion by 2030.

Radiopharmaceuticals are radioactive compounds used for diagnosis, treatment, and research within the medical field. They play a pivotal role in nuclear medicine, primarily used in imaging and therapeutic applications. The necessity of radiopharmaceuticals stems from their ability to target specific organs, tissues, or cellular receptors, thereby enabling precise diagnostic imaging and effective treatment of diseases like cancer, cardiovascular ailments, and neurological disorders. End-use applications primarily involve hospitals, diagnostic centers, and specialized clinics. Key influencing growth factors include an increasing prevalence of chronic diseases, advancements in imaging technologies, and a growing geriatric population, which drives the demand for precise diagnostic tools and personalized treatment strategies. The rapid advancements in radiopharmaceuticals for targeted therapy, along with rising investment in research and development, present significant opportunities. Companies could capitalize on these by focusing on niche indications or developing cost-effective and efficient production methods.

One limitation is the high cost related to the production and regulatory compliance inherent in handling radioactive materials, which poses a barrier to entry and innovation. Additionally, the need for sophisticated infrastructure and skilled personnel adds to market constraints. Intellectual property hurdles and a lengthy approval process further complicate rapid market penetration.

For business growth, research into new isotopes with better efficacy and lower side effects is promising. Innovation in imaging techniques and developing new clinical applications can pave the way for expansion. There is also potential in exploring collaborations between biotechnology firms and healthcare providers to integrate radiopharmaceuticals into existing treatment frameworks more effectively.

The nature of the market is highly regulated and competitive, with significant investments in R&D necessary for maintaining a competitive edge. As healthcare policies evolve and technology advances, adapting swiftly to these changes by focusing on emerging markets and untapped applications can provide strategic advantages.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radiopharmaceuticals Market

The Radiopharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Incidence and Prevalence of Target Conditions
  • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
  • Initiatives To Reduce The Demand-Supply Gap of mo-99
• Market Restraints
  • Shorter Life of Radiopharmaceuticals
• Market Opportunities
  • Adoption of Radiopharmaceuticals in Neurological Applications
  • Rising Number of Diagnostic Centers Especially in Developing Countries
• Market Challenges
  • High Equipment Prices and Limited Hospital Budget

Porter's Five Forces: A Strategic Tool for Navigating the Radiopharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radiopharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radiopharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radiopharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radiopharmaceuticals Market

A detailed market share analysis in the Radiopharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radiopharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radiopharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Radiopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Global Medical Solutions, Siemens Healthineers AG, Fusion Pharmaceuticals Inc., Novartis AG, International Isotopes, Inc., Northstar Medical Technologies LLC, Institute of Isotopes Co. Ltd., Jubilant Pharma Holdings Inc., IsoTherapeutics Group, LLC, Eckert & Ziegler Group, Isotopia Molecular Imaging Ltd., GE HealthCare Technologies, Inc., BWX Technologies. Inc., Clarity Pharmaceuticals, Eczacibasi-Monrol Nuclear Products Co., Alliance Holdings Medical Limited, Cardinal Health, Inc., Mallinckrodt PLC, Bracco Group, NTP Radioisotopes SOC Ltd., Curium Pharma, Medi-Radiopharma, Sinotau Pharmaceutical Group, State Atomic Energy Corporation Rosatom, SHINE Medical Technologies, Lantheus Medical Imaging, Inc., Bayer AG, and BWXT Medical Ltd..

Market Segmentation & Coverage

This research report categorizes the Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine is further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Pet Radiopharmaceuticals is further studied across F-18 and Ru-82. The Spect Radiopharmaceuticals is further studied across Ga-67, I-123, Tc-99m, and Tl-201. The Therapeutic Nuclear Medicine is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes. The Beta Emitters is further studied across I-131, Lu-177, Re-186, Sm-153, and Y-90. The Brachytherapy Isotopes is further studied across Cs-131, I-125, Ir-192, and Pd-103.
• Based on Procedural Volume, market is studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures is further studied across Pet Radiopharmaceutical Procedure and Spect Radiopharmaceuticals Procedure. The Therapeutic Procedures is further studied across Alpha Emitter Procedure, Beta Emitters Procedure, and Brachytherapy Isotopes Procedure.
• Based on Application, market is studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications is further studied across Pet Applications and Spect Applications. The Pet Applications is further studied across Cardiology Indication, Neurology Indication, and Oncology Indication. The Spect Applications is further studied across Cardiology, Lymphoma, Neurology, and Thyroid. The Therapeutic Applications is further studied across Bone Metastasis, Endocrine Tumors, Lymphoma Therapeutic, and Thyroid Therapeutic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
    • 5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
    • 5.1.1.3. Initiatives To Reduce The Demand-Supply Gap of mo-99
  • 5.1.2. Restraints
    • 5.1.2.1. Shorter Life of Radiopharmaceuticals
  • 5.1.3. Opportunities
    • 5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
    • 5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
  • 5.1.4. Challenges
    • 5.1.4.1. High Equipment Prices and Limited Hospital Budget
• 5.2. Market Segmentation Analysis
  • 5.2.1. Procedural Volume: Ongoing advancements in brachytherapy isotopes procedure
  • 5.2.2. Application: Increasing utilization of radiopharmaceuticals in therapeutic procedures
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Radiopharmaceuticals Market, by Type

• 6.1. Introduction
• 6.2. Diagnostic Nuclear Medicine
  • 6.2.1. Pet Radiopharmaceuticals
    • 6.2.1.1. F-18
    • 6.2.1.2. Ru-82
  • 6.2.2. Spect Radiopharmaceuticals
    • 6.2.2.1. Ga-67
    • 6.2.2.2. I-123
    • 6.2.2.3. Tc-99m
    • 6.2.2.4. Tl-201
• 6.3. Therapeutic Nuclear Medicine
  • 6.3.1. Alpha Emitters
  • 6.3.2. Beta Emitters
    • 6.3.2.1. I-131
    • 6.3.2.2. Lu-177
    • 6.3.2.3. Re-186
    • 6.3.2.4. Sm-153
    • 6.3.2.5. Y-90
  • 6.3.3. Brachytherapy Isotopes
    • 6.3.3.1. Cs-131
    • 6.3.3.2. I-125
    • 6.3.3.3. Ir-192
    • 6.3.3.4. Pd-103

7. Radiopharmaceuticals Market, by Procedural Volume

• 7.1. Introduction
• 7.2. Diagnostic Procedures
  • 7.2.1. Pet Radiopharmaceutical Procedure
  • 7.2.2. Spect Radiopharmaceuticals Procedure
• 7.3. Therapeutic Procedures
  • 7.3.1. Alpha Emitter Procedure
  • 7.3.2. Beta Emitters Procedure
  • 7.3.3. Brachytherapy Isotopes Procedure

8. Radiopharmaceuticals Market, by Application

• 8.1. Introduction
• 8.2. Diagnostic Applications
  • 8.2.1. Pet Applications
    • 8.2.1.1. Cardiology Indication
    • 8.2.1.2. Neurology Indication
    • 8.2.1.3. Oncology Indication
  • 8.2.2. Spect Applications
    • 8.2.2.1. Cardiology
    • 8.2.2.2. Lymphoma
    • 8.2.2.3. Neurology
    • 8.2.2.4. Thyroid
• 8.3. Therapeutic Applications
  • 8.3.1. Bone Metastasis
  • 8.3.2. Endocrine Tumors
  • 8.3.3. Lymphoma Therapeutic
  • 8.3.4. Thyroid Therapeutic

9. Americas Radiopharmaceuticals Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Radiopharmaceuticals Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Radiopharmaceuticals Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
  • 12.3.2. New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis
  • 12.3.3. With USD 56 Million, a Mayo Clinic-backed Startup takes aim at Radiopharmaceutical Roadblocks

Companies Mentioned

• 1. Global Medical Solutions
• 2. Siemens Healthineers AG
• 3. Fusion Pharmaceuticals Inc.
• 4. Novartis AG
• 5. International Isotopes, Inc.
• 6. Northstar Medical Technologies LLC
• 7. Institute of Isotopes Co. Ltd.
• 8. Jubilant Pharma Holdings Inc.
• 9. IsoTherapeutics Group, LLC
• 10. Eckert & Ziegler Group
• 11. Isotopia Molecular Imaging Ltd.
• 12. GE HealthCare Technologies, Inc.
• 13. BWX Technologies. Inc.
• 14. Clarity Pharmaceuticals
• 15. Eczacibasi-Monrol Nuclear Products Co.
• 16. Alliance Holdings Medical Limited
• 17. Cardinal Health, Inc.
• 18. Mallinckrodt PLC
• 19. Bracco Group
• 20. NTP Radioisotopes SOC Ltd.
• 21. Curium Pharma
• 22. Medi-Radiopharma
• 23. Sinotau Pharmaceutical Group
• 24. State Atomic Energy Corporation Rosatom
• 25. SHINE Medical Technologies
• 26. Lantheus Medical Imaging, Inc.
• 27. Bayer AG
• 28. BWXT Medical Ltd.